Helicobacter pylori infection after partial gastrectomy for peptic ulcer and its role in relapsing disease

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 4, 1997, Pages 373-374

  Leivonen, Marja K ^a   Haglund, Caj H ^b   Nordling, Stig F A ^c  

^a PEIJAS HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Helicobacter pylori; Partial gastrectomy; Peptic ulcer; Recurrence

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANASTOMOSIS; ARTICLE; FEMALE; GASTRECTOMY BILLROTH I; GASTRECTOMY BILLROTH II; GASTROINTESTINAL INFECTION; GASTROSCOPY; GIEMSA STAIN; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL GASTRECTOMY; PEPTIC ULCER; PRIORITY JOURNAL; RECURRENT PEPTIC ULCER; RETROSPECTIVE STUDY; SMOKING; STOMACH;

ADULT; AGED; BIOPSY; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GASTRIC MUCOSA; GASTROENTEROSTOMY; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH ULCER; VAGOTOMY;

EID: 0031002976     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-199704000-00010     Document Type: Article

References (25)

1. Goodwin CS: Duodenal ulcer, Campylobacter pylori, and the 'leaking roof' concept. Lancet 1988, ii: 1467-1469.
2. Tytgat CNJ, Rauws EAJ: Campylobacter pylori and its role in peptic ulcer disease. Gastroenterol Clin North Am1990, 19:183-196.
3. Yeomans ND: Bacteria in ulcer pathogenesis. Bailliere's Clin Gastroenterol1988, 2:573-591.
4. Coghlan JG, Humphries H, Dooley C, et al.: Campylobacter pylori and recurrence of duodenal ulcers - a 12-month follow-up study. Lancet 1987, ii:1109-1111.
5. Marshall BJ, Warren JR, Blincow ED, et al.: Prospective doubleblind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988, ii: 1437-1441.
6. Rauws EAJ, Tytgat GNJ: Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet1990, 335:1233-1235.
7. Boyd EJS, Johnston DA, Pension G, et al.: Does maintenance therapy keep duodenal ulcers healed? Lancet 1988, i:1324-1327.
8. Thomas JM, Misiewicz G: Histamine H-receptor antagonists in the short- and long-term treatment of duodenal ulcer. Clin Gastroenterol1984, 13:501-541.
9. Tytgat GNJ, Hameeteman W, van Olffen GH: Sucralfate, bismuth compounds, substituted benzimidazoles, trimipramine and pirenzepine in the short- and long-term treatment of duodenal ulcer. Clin Gastroenterol1984, 13:543-568.
10. Stabile BE, Passaro Jr E: Recurrent peptic ulcer. Gastroenterology1976, 70:124-135.
11. Thompson JC, Wiener I: Evaluation of surgical treatment of duodenal ulcer: short- and long-term effects. Clin Gastroenterol1984, 13:569-600.
12. Sipponen P, Helske T, Jarvinen P, et al.: Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985 and 1992. Gut 1994, 35:1167-1171.
13. Megraud F, Brassens-Rabbe M-P, Denis F, et al.: Seroepidemiology of Campylobacter pylori infection in various populations. JClin Microbiol 1989, 27:1870-1873.
14. Malaty HM, Engstrand L, Pedersen N, Graham DY: Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med1994, 120:982-986.
15. Aird I, Bentall HH, Mehigan JA, et al.: The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast and bronchus. BMJ 1954, ii:315-321.
16. Coggon D, Lambert P, Langman MJS: 20 years of hospital admissions for peptic ulcer in England and Wales. Lancet 1981, i:1302-1304.
17. Sonnenberg A: Factors which influence the incidence and course of peptic ulcer. Scand J Gastroenterol1988, 23(suppl.155): 119-139.
18. Janisch H-D, Witzel L, Niedobitek F, et al.: Campylobacter pylori in the operated stomach and its relationship to symptoms in th ese patients. In Gastroduodenal Pathology and Campylobacter pylori. Edited by Megraud F, Lamouliatte H. Amsterdam: Elsevier Science Publishers; 1989:517-519.
19. Loffeld RJLF, Loffeld BCAJ, Arends JW, et al.: The fate of Campylobacter pylori after partial gastrectomy. Does C. pylori have a role after surgery? A retrospective study. In Gastroduodenal Pathology and Campylobacter pylori. Edited by Megraud F, Lamouliatte H. Amsterdam: Elsevier Science Publishers; 1989:521-523.
20. O'Connor HJ, Wyatt JI, Ward DC, et al.: Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet 1986, ii:1178-1181.
21. Offerhaus GJA, Rieu PNMA, Jansen JBMJ, et al.: Prospective comparative study of the influence of postoperative bile reflux on gastric mucosal histology and Campylobacter pylori infection. Gut 1989, 30:1552-1557.
22. Tompkins DS, West AP: Campylobacter pylori, acid, and bile. J Clin Pathol1987, 40:1387.
23. Rieu PNMA, Jansen JBMI, Biemond I, et al.: Short-term results of gastrectomy with Roux-en-Y or Billroth II anastomosis for peptic ulcer. A prospective comparative study. Hepatogastroenterology1992, 39:22-26.
24. Ovaska JT, Ekfors TO, Luukkonen PE, et al.: Histological changes in the gastric stump mucosa and late clinical results after Billroth I, Billroth II and Roux-en-Y operations for peptic ulcer disease. Ann Chir Gynaecol1988, 77:1-5.
25. Lamers CBHW, Rieu PNMA, Veenendaal RA, et al.: Effect of partial gastrectomy on serum anti-Helicobacter pylori immunoglobulins in peptic ulcer patients. Dig Dis Sci1991, 36:1697-1701.